BiotechTube
Home/AbbVie/Scott T. Reents
ST

Scott T. Reents

Executive Vice President, Chief Financial Officer

AbbVie

Therapeutic Areas

ImmunologyOncologyNeuroscienceEye CareVirology

AbbVie Pipeline

DrugIndicationPhase
Humira (adalimumab)Rheumatoid arthritis, psoriasis, IBDApproved
Skyrizi (risankizumab)Psoriasis, Crohn's diseaseApproved
Rinvoq (upadacitinib)Rheumatoid arthritis, atopic dermatitisApproved
Imbruvica (ibrutinib)Blood cancersApproved
Venclexta (venetoclax)CLL, AMLApproved
Orilissa (elagolix)EndometriosisApproved
ABBV-951Parkinson's diseasePhase 3
ABBV-383Multiple myelomaPhase 1/2

Leadership Team at AbbVie

RA
Richard A. Gonzalez
Executive Chairman
RA
Robert A. Michael
Chief Executive Officer and President
TJ
Thomas J. Hudson
Executive Vice President, Chief Scientific Officer
CC
Carrie C. Smith
Executive Vice President, Chief Legal Officer
AS
Azita Saleki-Gerhardt
Executive Vice President, Chief Operating Officer
RT
Roopal Thakkar
Executive Vice President, Research and Development, Chief Scientific Officer
JR
Jeffrey Ryan Stewart
Executive Vice President, Chief Commercial Officer
JS
Jonathon Sedgwick
Senior Vice President, Global Regulatory Affairs
View full AbbVie profile